Angelo Maria Patti
Overview
Explore the profile of Angelo Maria Patti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bruno A, Di Sano C, Simon H, Chanez P, Patti A, Di Vincenzo S, et al.
Front Cell Dev Biol
. 2021 Jul;
9:700481.
PMID: 34327205
Adipose tissue is widely recognized as an extremely active endocrine organ producing adipokines as leptin that bridge metabolism and the immune system. Pre-B-cell leukemia homeobox (Pbx)-regulating protein-1 (PREP1) is a...
12.
Giglio R, Pantea Stoian A, Al-Rasadi K, Banach M, Patti A, Ciaccio M, et al.
Int J Mol Sci
. 2021 Apr;
22(9).
PMID: 33924893
Atherosclerosis is a multifactorial vascular disease that leads to inflammation and stiffening of the arteries and decreases their elasticity due to the accumulation of calcium, small dense Low Density Lipoproteins...
13.
Giglio R, Pantea Stoian A, Haluzik M, Pafili K, Patti A, Rizvi A, et al.
Biochim Biophys Acta Mol Basis Dis
. 2021 Apr;
1867(8):166148.
PMID: 33892081
Diabetes represents the leading risk factor for the development of cardiovascular disease (CVD). Chronic hyperglycemia and/or acute post-prandial changes in blood glucose determine an increase in reactive oxygen species (ROS),...
14.
Nikolic D, Giglio R, Rizvi A, Patti A, Montalto G, Maranta F, et al.
Diabetes Ther
. 2020 Nov;
12(1):261-274.
PMID: 33210276
Introduction: Liraglutide has several non-glycemic effects, including those on plasma lipids and lipoproteins, contributing to its cardiovascular benefit; however, the exact underlying mechanisms remain unclear. We investigated a novel anti-atherogenic...
15.
Giglio R, Carruba G, Cicero A, Banach M, Patti A, Nikolic D, et al.
Metabolites
. 2020 Oct;
10(11).
PMID: 33114614
Food supplementation with (OFI) has been associated with a significant reduction in total cholesterol, body fat, hyperglycemia and blood pressure. Since OFI may also have antioxidant and anti-atherogenic properties, we...
16.
Giglio R, Nikolic D, Volti G, Pantea Stoian A, Banerjee Y, Magan-Fernandez A, et al.
Metabolites
. 2020 Oct;
10(10).
PMID: 33008044
Liraglutide has shown favourable effects on several cardiometabolic risk factors, beyond glucose control. MicroRNAs (miRNAs) regulate gene expression, resulting in post-transcriptional modifications of cell response and function. Specific miRNAs, including...
17.
Pantea Stoian A, Sachinidis A, Stoica R, Nikolic D, Patti A, Rizvi A
Metabolism
. 2020 Jun;
109:154295.
PMID: 32553739
Introduction: The dipeptidyl peptidase-4 inhibitors (DPP-4is), which belong to the class of incretin-based medications, are recommended as second or third-line therapies in guidelines for the management of type 2 diabetes...
18.
Patti A, Rizvi A, Giglio R, Pantea Stoian A, Ligi D, Mannello F
J Clin Med
. 2020 Apr;
9(4).
PMID: 32225082
Type 2 Diabetes Mellitus (T2DM) is associated with a high risk of atherosclerotic cardiovascular (CV) disease. Among the well-known pathophysiologic factors, crucial roles are played by endothelial dysfunction (caused by...
19.
Patti A, Giglio R, Pafili K, Rizzo M, Papanas N
Expert Opin Pharmacother
. 2019 Mar;
20(8):983-989.
PMID: 30924387
Introduction: In women with type 1 diabetes mellitus (T1DM), pregnancy is associated with a potential risk of maternal, foetal and neonatal outcomes. Stringent metabolic control is required to improve these...
20.
Patti A, Nikolic D, Magan-Fernandez A, Giglio R, Castellino G, Chianetta R, et al.
Diabetes Res Clin Pract
. 2019 Feb;
149:163-169.
PMID: 30759365
Aim: To evaluate the effect of exenatide long acting release (LAR) on carotid intima-media thickness (IMT) and endothelial function in patients with type 2 diabetes mellitus. Methods: Sixty subjects with...